Community
Olivia Rodrigo ATL tickets: Last-minute options for sold-out ‘Unraveled Tour’ dates
By Michelle Rivera
Ozempic, Wegovy and Zepbound get new FDA warning over rare condition
Michelle Rivera
Michelle Rivera
Reporter · Cleveland, OH
Michelle, an Ohio State University graduate, has spent over six years focusing on community issues in Cleveland, including social justice and local initiatives. She has previously written for NPR's local affiliates, where she honed her storytelling skills to highlight diverse community voices.
More from Michelle →Reporter · Tuesday, November 10, 2026 at 2:33 PM · 1 min read
People taking popular weight-loss and diabetes drugs are getting a new safety warning. The Food and Drug Administration is requiring all GLP-1 drugs to carry information about a potential increased risk of a rare eye condition that can cause permanent vision loss, according to the FDA’s Nov. 9 drug safety communication. The medications include Ozempic, Wegovy, Mounjaro and Zepbound.
Up nextOlivia Rodrigo ATL tickets: Last-minute options for sold-out ‘Unraveled Tour’ datesCommunity · 1 min read
More Community stories
Community
Fall Out Boy tickets: How to get into 2027 tour during and after the presale
By Michelle Rivera
Community
Parker Messick’s Rookie of the Year finish exposes a familiar frustration for Cleveland
By Michelle Rivera
Community
Where to watch Coco Gauff vs. Linda Noskova tennis for free today
By Michelle Rivera